Techceuticals developed a suspension dosage form of a new ch…
Techceuticals developed a suspension dosage form of a new chemical entity and the product is subjected to accelerated stability studies. The stability analyst reported the following data after 12 weeks of the study. Which of the following would you consider as “significant change” in the product performance?
Read Details